Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc. (XLO) Stock Ticker

NASDAQ: XLO · Healthcare · Biotechnology
$9.04+0.44%
USD · as of 2026-09-27 · market cap $59.4M
Open XLO in TickrDownload for iPhone

XLO right now

Growing revenue 76% a year on 59% gross margins.
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full XLO picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on XLO
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to crafting immunotherapies aimed at strengthening the immune systems of cancer patients. A key part of their pipeline is XTX101, a tumor-selective anti-CTLA-4 monoclonal antibody that is currently undergoing Phase 1/2 clinical trials for various solid tumors. The company also develops a range of cytokine programs, including XTX202 (a modified IL-2), XTX301 (an IL-12 product candidate), and XTX401 (an IL-15 product candidate). These cytokine therapies are ingeniously engineered with a protein domain that keeps them inactive until proteases specific to the tumor microenvironment (TME) cleave this mask, thereby initiating their therapeutic activity. Xilio Therapeutics, Inc. was founded in 2016 and is based in Waltham, Massachusetts.

XLO stock facts

Ticker symbolXLO
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$59.4M
CEORene Russo
Employees76
HeadquartersWaltham, MA, US
IPO date2021-10-22
Websitewww.xiliotx.com

What you can see for XLO on Tickr

Live XLO price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the XLO report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Xilio Therapeutics, Inc.?

The ticker symbol for Xilio Therapeutics, Inc. is XLO, listed on the NASDAQ Global Select.

What is XLO?

Xilio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to crafting immunotherapies aimed at strengthening the immune systems of cancer patients. A key part of their pipeline is XTX101, a tumor-selective anti-CTLA-4 monoclonal antibody that is currently undergoing Phase 1/2 clinical trials for various solid tumors. The company also develops a range of cytokine programs,…

HomeExploreMarketLists
All pages